市場調査レポート
商品コード
1386998
放射性医薬品セラノスティクス市場レポート:2030年までの動向、予測、競合分析Radiopharmaceutical Theranostics Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
放射性医薬品セラノスティクス市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月16日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
放射性医薬品セラノスティクスの動向と予測
放射性医薬品セラノスティクスの世界市場は、2024年から2030年までのCAGRが11.2%で、2030年までに推定39億米ドルに達すると予想されます。この市場の主な促進要因は、がん罹患率の増加と心血管疾患治療への応用の増加です。放射性医薬品セラノスティクスの世界市場の将来は、病院、画像診断センター、学術・研究機関市場に機会があり、有望視されています。
放射性医薬品セラノスティクス市場の洞察
Lucintelは、PETトレーサーが予測期間中に最も高い成長を遂げると予測しています。
この市場において、病院は技術的に高度なシステムが利用可能であり、病院数が増加しているため、最大のセグメントであり続けると思われます。
北米は、慢性疾患の増加、放射性医薬品やペットスキャナーの入手が容易であることから、予測期間中に最も高い成長が見込まれます。
Radiopharmaceutical Theranostics Trends and Forecast
The future of the global radiopharmaceutical theranostics market looks promising with opportunities in the hospital, diagnostic imaging center, and academic & research institute markets. The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030 with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are increasing incidence of cancer and rising application in treatment of cardiovascular disorders.
A more than 150-page report is developed to help in your business decisions.
Radiopharmaceutical Theranostics by Segment
The study includes a forecast for the global radiopharmaceutical theranostics by product type, source, indication, end use, and region.
Radiopharmaceutical Theranostics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
Radiopharmaceutical Theranostics Market by Source [Shipment Analysis by Value from 2018 to 2030]:
Radiopharmaceutical Theranostics Market by Indication [Shipment Analysis by Value from 2018 to 2030]:
Radiopharmaceutical Theranostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Radiopharmaceutical Theranostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Radiopharmaceutical Theranostics Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies radiopharmaceutical theranostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the radiopharmaceutical theranostics companies profiled in this report include-
Radiopharmaceutical Theranostics Market Insights
Lucintel forecasts that PET tracers is expected to witness highest growth over the forecast period.
Within this market, hospitals will remain the largest segment due to availability of technologically advanced systems and rising number of hospitals.
North America is expected to witness highest growth over the forecast period due to the growing prevalence of chronic diseases and easy availability of radiopharmaceuticals and pet scanners in the region.
Features of the Global Radiopharmaceutical Theranostics Market
Market Size Estimates: Radiopharmaceutical theranostics market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Radiopharmaceutical theranostics market size by various segments, such as by product type, source, indication, end use, and region in terms of value ($B).
Regional Analysis: Radiopharmaceutical theranostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, sources, indications, end uses, and regions for the radiopharmaceutical theranostics market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the radiopharmaceutical theranostics market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the radiopharmaceutical theranostics market size?
Answer: The global radiopharmaceutical theranostics market is expected to reach an estimated $3.9 billion by 2030.
Q.2 What is the growth forecast for radiopharmaceutical theranostics market?
Answer: The global radiopharmaceutical theranostics market is expected to grow with a CAGR of 11.2% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the radiopharmaceutical theranostics market?
Answer: The major drivers for this market are increasing incidence of cancer and rising application in treatment of cardiovascular disorders.
Q4. What are the major segments for radiopharmaceutical theranostics market?
Answer: The future of the global radiopharmaceutical theranostics market looks promising with opportunities in the hospital, diagnostic imaging center, and academic & research institute markets.
Q5. Who are the key radiopharmaceutical theranostics market companies?
Answer: Some of the key radiopharmaceutical theranostics companies are as follows:
Q6. Which radiopharmaceutical theranostics market segment will be the largest in future?
Answer: Lucintel forecasts that PET tracers is expected to witness highest growth over the forecast period.
Q7. In radiopharmaceutical theranostics market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to the growing prevalence of chronic diseases and easy availability of radiopharmaceuticals and pet scanners in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.